MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: Oxaliplatin Phase 1 (Zyklen 1-6, dann abgebrochen)

Raw xml | Download


<MedicationStatement xmlns="http://hl7.org/fhir">
  <id value="mii-exa-onko-modification-oxaliplatin-phase1"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie-medikation"/>
  </meta>
  <language value="de"/>
  <text>
    <status value="generated"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: MedicationStatement mii-exa-onko-modification-oxaliplatin-phase1</b></p><a name="de-mii-exa-onko-modification-oxaliplatin-phase1"> </a><a name="de-hcmii-exa-onko-modification-oxaliplatin-phase1"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-onko-systemische-therapie-medikation.html">MII PR Onkologie Systemische Therapie Medikation</a></p></div><p><b>basedOn</b>: <a href="CarePlan-mii-exa-onko-tumorkonferenz-folfox-modification.html">CarePlan: identifier = Tumorkonferenz_FOLFOX_Modification_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-05</a></p><p><b>partOf</b>: <a href="Procedure-mii-exa-onko-folfox-phase1.html">Procedure Nicht komplexe Chemotherapie</a></p><p><b>status</b>: Stopped</p><p><b>statusReason</b>: <span title="Codes:{http://snomed.info/sct 281647001}">Grade 3 peripheral neuropathy (CTCAE) - cumulative neurotoxicity from oxaliplatin</span></p><p><b>medication</b>: <span title="Codes:{http://fhir.de/CodeSystem/bfarm/atc L01XA03}">Oxaliplatin</span></p><p><b>subject</b>: <a href="Patient-example-modification.html">Martin Beispiel  Male, DoB: 1958-11-03</a></p><p><b>effective</b>: 2024-03-15 --&gt; 2024-06-10</p><p><b>note</b>: </p><blockquote><div><p>FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities.</p>
</div></blockquote></div>
  </text>
  <basedOn>🔗 
    <reference
               value="CarePlan/mii-exa-onko-tumorkonferenz-folfox-modification"/>
  </basedOn>
  <partOf>🔗 
    <reference value="Procedure/mii-exa-onko-folfox-phase1"/>
  </partOf>
  <status value="stopped"/>
  <statusReason>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="281647001"/>
      <display value="Adverse reaction (disorder)"/>
    </coding>
    <text
          value="Grade 3 peripheral neuropathy (CTCAE) - cumulative neurotoxicity from oxaliplatin"/>
  </statusReason>
  <medicationCodeableConcept>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/atc"/>
      <code value="L01XA03"/>
      <display value="Oxaliplatin"/>
    </coding>
    <text value="Oxaliplatin"/>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/example-modification"/>
  </subject>
  <effectivePeriod>
    <start value="2024-03-15"/>
    <end value="2024-06-10"/>
  </effectivePeriod>
  <note>
    <text
          value="FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities."/>
  </note>
</MedicationStatement>